IP Library Granted Patent US 7,935,511
Granted Patent B2
US 7,935,511 · App. 11/763,424 · Granted May 3, 2011

Aerobic succinate production in bacteria

Assignee: Rice University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,935,511
App. No.
11/763,424
Granted
May 3, 2011
Kind
B2
Abstract

Methods of increasing yields of succinate using aerobic culture methods and a multi-mutant E. coli strain are provided. Also provided is a mutant strain of E. coli that produces high amounts of succinic acid.

Claims (14)

1. A mutant strain of E. coli bacteria wherein said mutant strain comprises inactivation of sdhAB, ackA-pta, and poxB.

2. The mutant strain of claim 1 , wherein said mutant strain of E. coli bacteria further comprises inactivation of i) ptsG, or ii) iclR, or iii) icd, or iv) both ptsG and iclR, or v) both icd and iclR, or v) ptsG, iclR, and icd.

3. The mutant strain of claim 1 , wherein said mutant strain of E. coli bacteria further comprises overexpression of pepc.

4. The mutant strain of claim 1 , wherein said mutant strain of E. coli bacteria further comprises inactivation of iclR and overexpresses pepc.

5. The mutant strain of claim 1 , wherein said mutant strain of E. coli bacteria further comprises inactivation of ptsG and iclR, and comprises overexpression of pepc.

6. The mutant strain of claim 1 , wherein the bacteria produces succinate at a ratio of at least 0.6:1 moles succinate per mole glucose.

7. A mutant strain of E. coli bacteria, wherein said mutant strain comprises:

i) inactivation of sdhAB, ackA-pta, poxB, and icd, and

ii) overexpression of pepc.

8. The mutant strain of claim 7 , wherein the bacteria produces succinate at a ratio of at least 0.6:1 moles succinate per mole glucose.

9. A mutant strain of E. coli bacteria, wherein said mutant strain comprises:

i) inactivation of sdhAB, ackA-pta, poxB, ptsG, icd, and iclR, and

ii) overexpression of pepc.

10. The mutant strain of claim 9 , wherein the bacteria produces succinate at a ratio of at least 0.9:1 moles succinate per mole glucose.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 17, 2012
From: RICE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 028225/0955 →
Continuity (4)
Division 10987511 · Nov 12, 2004
Provisional Application 60520216 · Nov 13, 2003
Provisional Application 60599956 · Aug 9, 2004
Related Publication 20070249028A1 · Oct 25, 2007